Glickman Mark A — SEC insider filings
SEC reporting owner CIK 1441461. 9 insider filings on record with FilingPulse; latest filed 2026-08-28.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2021-10-15 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 440 shares, $2,165 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 440 shares @ $4.92 ($2,165) in TherapeuticsMD, Inc., filed 2022-12-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | Co-Chief Executive Officer | 4 | — | 1 leg · 440 sh · $2,165 | 7 |
| MetaVia Inc. (MTVA) | Director | 4 | — | — | 5 |
| BioStem Technologies, Inc. (BSEM) | Director | 1 | — | — | 2 |
Insider filings — Glickman Mark A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4 | BioStem Technologies, Inc. (BSEM) | Option exercise (M): 7,671 @ $0 · Option exercise (M): 7,671 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | MetaVia Inc. (MTVA) | Grant/award (A): 17,186 @ $0 | EDGAR |
| 2025-07-01 | 4 | MetaVia Inc. (MTVA) | Grant/award (A): 28,147 @ $0 | EDGAR |
| 2024-06-07 | 4 | NeuroBo Pharmaceuticals, Inc. (NRBO) | Grant/award (A): 5,051 @ $0 | EDGAR |
| 2023-07-28 | 4 | NeuroBo Pharmaceuticals, Inc. (NRBO) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 12,500 @ $0 | EDGAR |
| 2022-12-09 | 4 | TherapeuticsMD, Inc. (TXMD) | Option exercise (M): 1,734 @ $0 · Sale (S): 440 @ $4.92 · Option exercise (M): 1,734 (derivative) @ $0 | EDGAR |
| 2022-03-31 | 4 | TherapeuticsMD, Inc. (TXMD) | Grant/award (A): 260,000 (derivative) @ $0 | EDGAR |
| 2022-03-28 | 4 | TherapeuticsMD, Inc. (TXMD) | Grant/award (A): 260,000 (derivative) @ $0 | EDGAR |
| 2021-10-15 | 4 | TherapeuticsMD, Inc. (TXMD) | Grant/award (A): 260,000 (derivative) @ $0 · Grant/award (A): 260,000 (derivative) @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-10-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1441461 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs